Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
CANDEL THERAPEUTICS, INC.
www.candeltx.comAI Executive Summary
AI-powered analysis of 8-K filing content
Candel Therapeutics held its Annual Meeting of Stockholders on June 23, 2026, electing four new Class II directors to serve until 2029 and ratifying KPMG LLP as the independent auditor. This routine governance event reflects normal board succession and audit oversight.
Key Takeaways
Four Class II directors were elected: Edward J. Benz Jr. M.D., Paul B. Manning, Maha Radhakrishnan M.D., and Paul Peter Tak M.D., Ph.D., FMedSci, serving until the 2029 annual meeting
KPMG LLP was ratified as the company's independent auditor for the fiscal year
1 more takeaway